Collplant Biotechnologies Stock Analysis

Collplant Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Collplant Biotechnologies recorded a loss per share of 1.53. The entity last dividend was issued on the 21st of November 2016. The firm had 2:3 split on the 21st of November 2016. CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. CollPlant Biotechnologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 66 people. For more info on Collplant Biotechnologies please contact Yehiel Tal at 972 73 232 5600 or go to https://www.collplant.com.

Collplant Biotechnologies Investment Alerts

Collplant Biotechnologies Upcoming and Recent Events

Collplant Largest EPS Surprises

View All Earnings Estimates

Collplant Biotechnologies Environmental, Social, and Governance (ESG) Scores

Collplant Stock Institutional Investors

Note, although Collplant Biotechnologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Collplant Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.07 M.

Collplant Profitablity

Management Efficiency

Collplant Biotechnologies has return on total asset (ROA) of (0.3822) % which means that it has lost $0.3822 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7065) %, meaning that it created substantial loss on money invested by shareholders. Collplant Biotechnologies' management efficiency ratios could be used to measure how well Collplant Biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of March 2025, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.23. At this time, Collplant Biotechnologies' Total Assets are very stable compared to the past year. As of the 27th of March 2025, Other Current Assets is likely to grow to about 283.1 K, while Non Current Assets Total are likely to drop about 3.8 M.

Technical Drivers

As of the 27th of March, Collplant Biotechnologies shows the Standard Deviation of 3.57, mean deviation of 2.54, and Risk Adjusted Performance of (0.09). Collplant Biotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Collplant Biotechnologies Price Movement Analysis

Collplant Biotechnologies Outstanding Bonds

Collplant Biotechnologies Predictive Daily Indicators

Collplant Biotechnologies Corporate Filings

Collplant Biotechnologies Forecast Models

Collplant Biotechnologies' time-series forecasting models are one of many Collplant Biotechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Collplant Biotechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Collplant Biotechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Collplant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Collplant Biotechnologies. By using and applying Collplant Stock analysis, traders can create a robust methodology for identifying Collplant entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Collplant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Collplant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Collplant Biotechnologies stock analysis indicators help investors evaluate how Collplant Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Collplant Biotechnologies shares will generate the highest return on investment. By understating and applying Collplant Biotechnologies stock analysis, traders can identify Collplant Biotechnologies position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.